Social networks
400Activities
Technologies
Entity types
Location
Bio City, Pennyfoot St, Nottingham NG1 1GF, UK
Nottingham
United Kingdom
Employees
Scale: 2-10
Estimated: 13
Engaged corporates
0Added in Motherbase
4 months, 2 weeks agoIsomAb is taking a different approach to identify, evaluate and develop isoform specific antibodies to treat disease where patients currently have limited or no treatment options.
IsomAb is developing isoform specific antibodies and it has identified, using a combined bioinformatics/knowledge-based platform approach, ISM-001 which specifically inhibits the VEGF-A165b isoform of Vascular Endothelial Growth Factor-A (VEGF-A); based on 20 years of research by our two Founders, the evidence shows reducing serum levels of VEGF-A165b is key to ensuring new blood vessel formation in patients with ischemic disease.